535 related articles for article (PubMed ID: 28379023)
1. [Cardiovascular complications of cancers and anti-cancer therapy].
Vyskočil J; Petráková K; Jelínek P; Furdek M
Vnitr Lek; 2017; 63(3):200-209. PubMed ID: 28379023
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Outcomes in Survivors of Pediatric and Adult Cancers.
Nathan PC; Amir E; Abdel-Qadir H
Can J Cardiol; 2016 Jul; 32(7):871-80. PubMed ID: 27179545
[TBL] [Abstract][Full Text] [Related]
3. Cardiotoxicity among adult survivors suffered from childhood malignancies.
Petropoulos AC; Moschovi M
Hell J Nucl Med; 2019; 22 Suppl 2():34-40. PubMed ID: 31802042
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.
Boekel NB; Schaapveld M; Gietema JA; Russell NS; Poortmans P; Theuws JC; Schinagl DA; Rietveld DH; Versteegh MI; Visser O; Rutgers EJ; Aleman BM; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1061-72. PubMed ID: 27026313
[TBL] [Abstract][Full Text] [Related]
5. Cardiotoxicity of cancer chemotherapy: implications for children.
Simbre VC; Duffy SA; Dadlani GH; Miller TL; Lipshultz SE
Paediatr Drugs; 2005; 7(3):187-202. PubMed ID: 15977964
[TBL] [Abstract][Full Text] [Related]
6. Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention.
Narayan V; Ky B
Annu Rev Med; 2018 Jan; 69():97-111. PubMed ID: 29414258
[TBL] [Abstract][Full Text] [Related]
7. Cardiac complications in childhood cancer survivors treated with anthracyclines.
Franco VI; Lipshultz SE
Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
[TBL] [Abstract][Full Text] [Related]
8. Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician.
Dillenburg RF; Nathan P; Mertens L
Eur J Pediatr; 2013 Sep; 172(9):1149-60. PubMed ID: 23361962
[TBL] [Abstract][Full Text] [Related]
9. Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors.
Mavrogeni SI; Sfendouraki E; Markousis-Mavrogenis G; Rigopoulos A; Noutsias M; Kolovou G; Angeli C; Tousoulis D
Heart Fail Rev; 2019 Nov; 24(6):977-987. PubMed ID: 31134427
[TBL] [Abstract][Full Text] [Related]
10. Cardio-oncology: cardiovascular complications of cancer therapy.
Henning RJ; Harbison RD
Future Cardiol; 2017 Jul; 13(4):379-396. PubMed ID: 28660778
[TBL] [Abstract][Full Text] [Related]
11. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
Tajiri K; Aonuma K; Sekine I
Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
[TBL] [Abstract][Full Text] [Related]
12. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
Jensen BV
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
[TBL] [Abstract][Full Text] [Related]
13. Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management.
Steingart RM; Yadav N; Manrique C; Carver JR; Liu J
Semin Oncol; 2013 Dec; 40(6):690-708. PubMed ID: 24331191
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease in cancer survivors.
Okwuosa TM; Anzevino S; Rao R
Postgrad Med J; 2017 Feb; 93(1096):82-90. PubMed ID: 28123076
[TBL] [Abstract][Full Text] [Related]
15. High risk of symptomatic cardiac events in childhood cancer survivors.
van der Pal HJ; van Dalen EC; van Delden E; van Dijk IW; Kok WE; Geskus RB; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC
J Clin Oncol; 2012 May; 30(13):1429-37. PubMed ID: 22473161
[TBL] [Abstract][Full Text] [Related]
16. Long-term risk of congestive heart failure in younger breast cancer survivors: A nationwide study by the SMARTSHIP group.
Lee J; Hur H; Lee JW; Youn HJ; Han K; Kim NW; Jung SY; Kim Z; Kim KS; Lee MH; Han SH; Jung SH; Chung IY
Cancer; 2020 Jan; 126(1):181-188. PubMed ID: 31454422
[TBL] [Abstract][Full Text] [Related]
17. Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?
Riccio G; Coppola C; Piscopo G; Capasso I; Maurea C; Esposito E; De Lorenzo C; Maurea N
Hum Vaccin Immunother; 2016 May; 12(5):1124-31. PubMed ID: 26836985
[TBL] [Abstract][Full Text] [Related]
18. Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study.
Chung IY; Lee JW; Moon HG; Shin KH; Han W; Son BH; Ahn SH; Noh DY
Breast; 2020 Oct; 53():125-129. PubMed ID: 32771950
[TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study.
Puckett LL; Saba SG; Henry S; Rosen S; Rooney E; Filosa SL; Gilbo P; Pappas K; Laxer A; Eacobacci K; Kapyur AN; Robeny J; Musial S; Chaudhry A; Chaudhry R; Lesser ML; Riegel A; Ramoutarpersaud S; Rahmani N; Shah A; Papas V; Dawodu T; Charlton J; Knisely JPS; Lee L
Cancer Med; 2021 Aug; 10(15):5051-5061. PubMed ID: 34245128
[TBL] [Abstract][Full Text] [Related]
20. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.
Pai VB; Nahata MC
Drug Saf; 2000 Apr; 22(4):263-302. PubMed ID: 10789823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
